explore -WSS

explore

author：comprehensive 2025-10-01 01:49:20 - browse：11

Each COVID-19 vaccine vial from various companies is placed on individual rectangular backgrounds. Pfizer-BioNTech is positioned in the middle on a purple block adorned with two glitter star stickers, Moderna is on the top right on a red block, Janssen is on the bottom right on a blue block, and AstraZeneca is on the left on a red block. — Illustration: Christine Kao/STAT; Photos: Getty

It’s been four years since Covid-19 emerged, igniting a pandemic that killed millions of people and brought the world to its knees. A key factor in taming the pandemic was the creation of effective vaccines, which have saved millions of lives.

You’d think developing a successful vaccine would be an unmitigated win, from a financial perspective. And, indeed, for Pfizer and its partner BioNTech, as well as for Moderna — whose vaccines were the most widely used in the United States and much of the world — the revenues generated were absolutely staggering. But investors have shrugged at those sales as gains that will not be repeated.

Total sales of the Pfizer/BioNTech vaccine surpassed $80 billion, and more than 400 million doses of the shot and subsequent boosters have been administered in the U.S. alone. But the company’s stock price fell 32% over the past five years. Meanwhile, AstraZeneca, which told STAT it has not booked sales from its vaccine since last April and does not expect future sales, has seen its share price rise 64%. Merck, which saw its vaccine efforts fail twice, is up 56%.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： George Santos makes 1st court appearance after pleading not guilty to 13 counts
Next article： Prosecutors say FTX founder Sam Bankman

Wikipedia

WSS

Prosecutors say FTX founder Sam Bankman

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Biogen nominates mother of director’s child to replace him on board

The thinking behind the controversial eating disorder chatbot Tessa

Study: Misdiagnosis causes 800,000 deaths, serious disabilities a year in U.S.

A public health expert passes on football's full body collisions for youths

hotspot

explore

focus

After affirmative action ruling, medical educators look to 'holistic review'

It's time to take a new tack for treating Alzheimer's

How to save PrEP access — and even expand it

Mom launches Girl Scout troop for LGBTQ youth in Texas

Apple is now the first public company to be valued at $3 trillion

Listen: BridgeBio's big week & Lilly's Alzheimer's data

FDA approval of Sarepta Duchenne genetic therapy gives me hope

How to fix the rural physician shortage in the U.S.

Hollywood unions extend contract negotiations for actors

Why Marc Tessier

entertainment

Hey, doctors: Don't be no

Why Marc Tessier

A new deal aims to ramp up use of AI in rehab care decisions

Biden, Billy Joel, Elton John lead tributes for Tony Bennett after singer's death at 96

Novo: Oral version of Ozempic leads to 15% weight loss

Eli Lilly’s Mounjaro succeeds in second weight

Wikipedia

entertainment

Wikipedia

explore